CIK 0001478320
- Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 270907024
- Phone
- +1 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- 4 Open-market sale Chief Medical Officer sold 2,373 shares at $12.01 ($28,500)
- 4 Open-market sale President sold 4,613 shares at $12.01 ($55,402)
- 4 Open-market sale Chief Business Development Off sold 2,670 shares at $12.01 ($32,067)
- 4 Open-market sale SVP and General Counsel sold 1,569 shares at $12.01 ($18,844)
- 4 Open-market sale Principal Accounting Officer sold 220 shares at $12.01 ($2,642)
- 4 Open-market sale Chief People Officer sold 1,569 shares at $12.01 ($18,844)
- 4 Open-market sale Chief Scientific Officer sold 4,517 shares at $12.01 ($54,249)
- 4 Open-market sale CEO and Chairman sold 4,424 shares at $12.01 ($53,132)
- 4 Open-market sale Chief Operating Officer sold 1,244 shares at $12.01 ($14,940)
- 4 Grant or award Director acquired 6,689 shares (grant or award)
- 4 Grant or award Director acquired 6,689 shares (grant or award)
- 4 Grant or award Director acquired 6,689 shares (grant or award)
- 4 Grant or award Director acquired 6,689 shares (grant or award)
- 4 Grant or award Director acquired 6,689 shares (grant or award)
- 4 Grant or award Director acquired 6,689 shares (grant or award)
- 4 Grant or award Director acquired 6,689 shares (grant or award)
- 4 Open-market sale Chief Operating Officer sold 1,021 shares at $23.32 ($23,810)
- 4 Open-market sale SVP and General Counsel sold 15,338 shares at $30.00 ($460,140)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at $30.00 ($300,000)
- 4 Open-market sale Chief Scientific Officer sold 4,000 shares at an average $32.00 ($127,993)
Page 10 of 28 · 544 filings